Task: Answer the multiple-choice question.
Question: Which drug exhibits a 8.724% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. c1ccc(CN2CCN(c3nc(-c4ccccc4)nc4ccccc34)CC2)cc1
b. CCOC(=O)C1CCN(C(=O)C2CCN(S(=O)(=O)c3c(C)noc3C)CC2)CC1
Answer: a. c1ccc(CN2CCN(c3nc(-c4ccccc4)nc4ccccc34)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
c1ccc(CN2CCN(c3nc(-c4ccccc4)nc4ccccc34)CC2)cc1
c1ccc(CN2CCN(c3nc(-c4ccccc4)nc4ccccc34)CC2)cc1
4-(4-benzylpiperazin-1-yl)-2-phenylquinazoline